November 1, 2022 – PHILADELPHIA – Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
2022
Increased Risk of Death in Patients With Advanced Melanoma After Immune-Related Adverse Events
Melanoma is the deadliest of skin cancers. It develops in cells that produce melanin (the pigment that gives skin its color), otherwise known as melanocytes.
New AI tool can predict melanoma recurrence
Most deaths from melanoma — the most lethal form of skin cancer — occur in patients who were initially diagnosed with early stage melanoma and then later experienced a recurrence, which typically goes undetected until it has spread or metastasized.
In Phase 3 Trial, Tumor-Infiltrating Cells Found Highly Effective in Advanced Melanoma
A phase 3 trial comparing tumor-infiltrating cells (TILs) and a checkpoint inhibitor for the treatment of advanced melanoma favored TILs for every end point.